The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.

The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.

BACKGROUND: The intra-tumor stroma percentage in colon cancer (CC) patients has previously been reported by our group as a strong independent prognostic parameter. Patients with a high stroma percentage within the primary tumor have a poor prognosis. PATIENTS AND METHODS: Tissue samples from the mo...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Huijbers, A, Tollenaar, R, v Pelt, G, Zeestraten, E, Dutton, S, McConkey, C, Domingo, E, Smit, V, Midgley, R, Warren, B, Johnstone, E, Kerr, D, Mesker, W
التنسيق: Journal article
اللغة:English
منشور في: 2013

مواد مشابهة

مواد مشابهة